#United States #Cleveland #regenerative medicine #Aeris Biosciences #bioaerogels

Aeris Biosciences™: Redefining Regenerative Medicine

Aeris Biosciences™, the newly branded identity of Auxilium Health, signifies a transformative step in the field of regenerative biomaterials. Announced on July 28, 2026, this rebranding reflects the company's commitment to not only maintaining its original mission but also evolving its vision in alignment with modern medical needs. Since its inception, the organization has focused on restoring human health, and the new name encapsulates its ongoing dedication to this cause.

The cornerstone of Aeris's innovation lies within its state-of-the-art bioaerogel platform. This platform boasts a groundbreaking class of three-dimensional bioaerogels specifically designed to inhibit bacterial colonization while facilitating tissue regeneration. It offers clinicians unprecedented control over healing processes across a range of applications, including wound repair, bone regeneration, and therapeutic delivery.

A New Identity with a Continuous Mission

The name Aeris demonstrates a commitment to the principles of lightness and spatial freedom intrinsic to its biomaterials. By incorporating the term “Aer™,” the company emphasizes a foundational aspect of its products: the seamless integration with the biological healing processes of the human body. “Biosciences” grounds the brand in science and clinical efficacy, which together position Aeris as a leader at the forefront of regenerative medicine.

Over time, the demands of the medical community have evolved, and so have the expectations surrounding biomaterials. Traditionally regarded as passive agents, materials used in healing often lacked the dynamism required to assist in patient recovery effectively. Aeris acknowledges this challenge, asserting that biomaterials should actively shape the healing environment instead of merely serving as inert surfaces. This foundational belief fuels the vision for Aeris, where materials are developed with an innate ability to sense and respond to the body's needs, significantly accelerating the healing process.

Vision for the Future

Isaiah Kaiser, PhD, the visionary founder and CEO of Aeris Biosciences™, expresses his commitment to the company's mission by stating, "The name is new, but the promise behind it isn't. We built this company to restore human health, and every product we develop still answers that. Behind every wound, every implant, every difficult recovery is a person waiting to heal." His vision resonates throughout the organization, motivating the team to focus on patient-centered solutions that empower recovery and restoration.

Aeris is particularly excited about its lead product, which is currently advancing toward FDA clearance and clinical studies. This is a momentous achievement for the company as it seeks to improve the landscape of wound care and regenerative therapies.

Community and Collaboration

Headquartered in the Cleveland Clinic's Global Innovation Center, Aeris Biosciences™ is bolstered by support from prominent institutions including the National Science Foundation and the Ohio Department of Development. The company is poised to be a key player in the polymer industry cluster, indicating a stronger collaborative network aimed at pushing innovation boundaries in healthcare.

In conclusion, Aeris Biosciences™, as the new face of Auxilium Health, embodies a blend of innovation, dedication, and scientific rigor. The transition marks not only a branding shift but also a new commitment to enhancing human health through advanced biomaterials. By enabling faster, safer, and more predictable healing for patients, Aeris aims to lead the way into a future where clinical practitioners can rely on progressive biomaterials to support the recovery journeys of their patients. For more information, visit aerisbio.com and stay connected with Aeris through LinkedIn.

• ---